September 27, 2021
Axcel mandates investment bank Carnegie for an exit of in-vitro diagnostics equipment firm Aidian (formerly Orion Diagnostica) - a portfolio firm since 2018 now marketed at 2021 EBITDA of EUR 20m following a significant boost from Covid-19 and a Benelux bolt-on earlier this year (NKP Proprietary)
NKP | M&A Insights Proprietary
Headline from pre-deal coverage in M&A Insights